BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 31032948)

  • 21. Hypoxia inducible factor-1α directly induces the expression of receptor activator of nuclear factor-κB ligand in periodontal ligament fibroblasts.
    Park HJ; Baek KH; Lee HL; Kwon A; Hwang HR; Qadir AS; Woo KM; Ryoo HM; Baek JH
    Mol Cells; 2011 Jun; 31(6):573-8. PubMed ID: 21533547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF-1α regulates osteoclast activation and mediates osteogenesis during mandibular bone repair via CT-1.
    Tian Y; Shao Q; Tang Y; Li X; Qi X; Jiang R; Liang Y; Kang F
    Oral Dis; 2022 Mar; 28(2):428-441. PubMed ID: 33274496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipose mesenchymal stem cell-derived exosomes ameliorate hypoxia/serum deprivation-induced osteocyte apoptosis and osteocyte-mediated osteoclastogenesis in vitro.
    Ren L; Song ZJ; Cai QW; Chen RX; Zou Y; Fu Q; Ma YY
    Biochem Biophys Res Commun; 2019 Jan; 508(1):138-144. PubMed ID: 30473217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis.
    Li CH; Zhao JX; Sun L; Yao ZQ; Deng XL; Liu R; Liu XY
    Biochem Biophys Res Commun; 2013 Jun; 435(4):533-9. PubMed ID: 23665018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells.
    Niu G; Briggs J; Deng J; Ma Y; Lee H; Kortylewski M; Kujawski M; Kay H; Cress WD; Jove R; Yu H
    Mol Cancer Res; 2008 Jul; 6(7):1099-105. PubMed ID: 18644974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
    Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
    J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-1α disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expression.
    Shao J; Zhang Y; Yang T; Qi J; Zhang L; Deng L
    In Vitro Cell Dev Biol Anim; 2015 Sep; 51(8):808-14. PubMed ID: 25859979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
    Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
    J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragaloside IV protects cardiomyocytes against hypoxia injury via
    Li B; Yu J; Liu P; Zeng T; Zeng X
    Ann Transl Med; 2021 Sep; 9(18):1435. PubMed ID: 34733987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin
    Ma J; Wang A; Zhang H; Liu B; Geng Y; Xu Y; Zuo G; Jia P
    Bone; 2022 Nov; 164():116511. PubMed ID: 35933095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE.
    Kulkarni RN; Bakker AD; Everts V; Klein-Nulend J
    Calcif Tissue Int; 2010 Nov; 87(5):461-8. PubMed ID: 20725825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High glucose alters the secretome of mechanically stimulated osteocyte-like cells affecting osteoclast precursor recruitment and differentiation.
    Maycas M; Portolés MT; Matesanz MC; Buendía I; Linares J; Feito MJ; Arcos D; Vallet-Regí M; Plotkin LI; Esbrit P; Gortázar AR
    J Cell Physiol; 2017 Dec; 232(12):3611-3621. PubMed ID: 28138960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement.
    Shu R; Bai D; Sheu T; He Y; Yang X; Xue C; He Y; Zhao M; Han X
    PLoS One; 2017; 12(1):e0167312. PubMed ID: 28081119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-adrenergic signaling affect osteoclastogenesis via osteocytic MLO-Y4 cells' RANKL production.
    Yao Q; Liang H; Huang B; Xiang L; Wang T; Xiong Y; Yang B; Guo Y; Gong P
    Biochem Biophys Res Commun; 2017 Jul; 488(4):634-640. PubMed ID: 27823934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways.
    Li CH; Xu LL; Jian LL; Yu RH; Zhao JX; Sun L; Du GH; Liu XY
    Int Immunopharmacol; 2018 May; 58():136-144. PubMed ID: 29587202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose uptake inhibition decreases expressions of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteocalcin in osteocytic MLO-Y4-A2 cells.
    Takeno A; Kanazawa I; Notsu M; Tanaka KI; Sugimoto T
    Am J Physiol Endocrinol Metab; 2018 Feb; 314(2):E115-E123. PubMed ID: 29018002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enriched housing promotes post-stroke neurogenesis through calpain 1-STAT3/HIF-1α/VEGF signaling.
    Wu X; Liu S; Hu Z; Zhu G; Zheng G; Wang G
    Brain Res Bull; 2018 May; 139():133-143. PubMed ID: 29477834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
    Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
    J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.
    Azab E; Chandler KB; Uda Y; Sun N; Hussein A; Shuwaikan R; Lu V; Costello CE; McComb ME; Divieti Pajevic P
    FASEB J; 2020 Aug; 34(8):10191-10211. PubMed ID: 32557809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
    Doi K; Murata K; Ito S; Suzuki A; Terao C; Ishie S; Umemoto A; Murotani Y; Nishitani K; Yoshitomi H; Fujii T; Watanabe R; Hashimoto M; Murakami K; Tanaka M; Ito H; Park-Min KH; Ivashkiv LB; Morinobu A; Matsuda S
    Arthritis Rheumatol; 2022 Jun; 74(6):948-960. PubMed ID: 35077015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.